Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04898270
What this trial is testing

Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

Who this might be right for
Schizophrenia; PsychosisMetabolic SyndromeFlupentixol+5 more
Taichung Veterans General Hospital 30
Post-approval studies (Phase 4)Study completedNCT00816907
What this trial is testing

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 146
Post-approval studies (Phase 4)Study completedNCT00216671
What this trial is testing

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 220
Not applicableStudy completedNCT01786239
What this trial is testing

Omega-3 Dietary Supplements in Schizophrenia

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder+2 more
Delbert Robinson 50
Post-approval studies (Phase 4)Study completedNCT00001656
What this trial is testing

Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders

Who this might be right for
Childhood SchizophreniaPsychotic DisorderSchizophrenia
National Institute of Mental Health (NIMH) 25
Large-scale testing (Phase 3)Study completedNCT00216476
What this trial is testing

Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag International NV 753
Not applicableStudy completedNCT00956189
What this trial is testing

Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

Who this might be right for
Metabolic Syndrome X
National Taiwan University Hospital 132
Large-scale testing (Phase 3)Ended earlyNCT01760889
What this trial is testing

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 1
Post-approval studies (Phase 4)Study completedNCT00763438
What this trial is testing

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 18
Not applicableStudy completedNCT00399776
What this trial is testing

Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy

Who this might be right for
Adolescent Depression
Creighton University 60
Large-scale testing (Phase 3)Study completedNCT00107939
What this trial is testing

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Who this might be right for
Bipolar Disorder
Novartis Pharmaceuticals 453
Post-approval studies (Phase 4)WithdrawnNCT06107829
What this trial is testing

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Who this might be right for
Tardive DyskinesiaIntellectual DisabilityDevelopmental Disabilities
Stephen Ruedrich
Early research (Phase 1)Study completedNCT01552772
What this trial is testing

Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 60
Not applicableEnded earlyNCT01420575
What this trial is testing

Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
VA Nebraska Western Iowa Health Care System 8
Early research (Phase 1)Study completedNCT02079844
What this trial is testing

Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

Who this might be right for
Schizophrenia
Takeda 20
Large-scale testing (Phase 3)Study completedNCT00044681
What this trial is testing

The Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepression
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258
Post-approval studies (Phase 4)Study completedNCT02697045
What this trial is testing

Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch

Who this might be right for
Schizophrenia
Abdi İbrahim Otsuka 23
Large-scale testing (Phase 3)Study completedNCT00236587
What this trial is testing

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100
Not applicableStudy completedNCT00161031
What this trial is testing

Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 30
Post-approval studies (Phase 4)Study completedNCT00682448
What this trial is testing

Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

Who this might be right for
Metabolic Complications
Rush University Medical Center 25
Next Page